USPTO serial 79060962
P.L.E.A.S.E
Reviewed by CopyMark Law Group
Reg. 3699132Status 404
- Filing date
- Status date
- Registration date
- Oct 20, 2009
- Examiner
- MIDDLETON, BERNICE L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with P.L.E.A.S.E?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jacqueline Zion
Jacqueline Zion Pearl Cohen Zedek Latzer Baratz LLP1500 Broadway, 12th FLNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the prevention and treatment of infertility, osteo-Arthritis, pain, enopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; veterinary preparations for the prevention and treatment of joint injuries; chemical-pharmaceutical preparations for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; chemical preparations for harmaceutical purposes for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; chemical preparations for medical purposes for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; pharmaceutical preparations and substances for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases, including vaccines and transdermal drug delivery patches with medication; medicines for human medical purposes for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases including vaccines and transdermal drug delivery patches with medication; medicines for veterinary purposes for the prevention and treatment of joint injuries; bacteriological and biological preparations for medical or veterinary purposes for the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases including vaccines and transdermal drug delivery patches with medication; bacterial preparations for medical or veterinary purposes; diagnostic agents for medical purposes; adhesive tapes and adhesive strips for medical purposes; plasters for medical purposes; transdermal patches for use in the prevention and treatment of infertility, osteo-Arthritis, pain, menopausal hormone deficiency, primary and secondary amenorrhea, rejection of transplanted organs and limbs, endometriosis, inflammation, thrombosis, psoriasis, Parkinson's disease, diabetes, cancer, multiple sclerosis, allergic conditions, vascular diseases, metabolic diseases, neurological disorders, high risk pregnancy, chronic forms of above mentioned diseases | SECTION 71 - CANCELLED | — |
| 009 | Computer software for the operation of and treatment with medical and aesthetic laser, energy delivery and energy emitting devices | SECTION 71 - CANCELLED | — |
| 010 | Surgical, medical, dental and veterinary instruments and apparatus, namely, lasers for surgical and medical use, medical electrode arrays, disposable tips for medical and surgical laser apparatus, metallic filaments; medical apparatus and instruments, namely, apparatus for ablation and poration of biological tissue by means of radio frequency, heat pulses and laser energy, medical laser apparatus, iontophoresis apparatus, handheld and stationary apparatus for glucose monitoring, medical apparatus for cell processing and/or cell cultivating and/or cell storage, inhalers for medical purposes, meter dose inhalers for medical purposes, apparatus for transdermal analyte extraction; apparatus, plasters and containers for the dispensing of medicines, namely, drug delivery systems all sold without medication; transdermal medicine administration apparatus, namely, refillable patches and dry patches without medication; analysis apparatus for medical purposes, namely, blood, cell, substance, molecular analysis or cell separation apparatus, namely, laser based cell separators; medical iontophoretic apparatus and intradermal apparatus, namely, drug delivery systems; medical apparatus for the perforation or for the removal of skin, tissue or organs; diagnostic apparatus for medical purposes; electrodes for medical purposes, namely, electrodes for the ablation and poration of biological tissue, namely, the skin; lasers and laser apparatus for medical purposes; lasers and laser apparatus for aesthetic purposes, namely, for removal of port wine stains, removal of warts, removal of old age spots, fine line wrinkle reduction, mid and deep wrinkle reduction, delivery of cosmaceuticals; medical and aesthetic energy delivery or energy emitting devices, namely, electromagnetic radiation apparatus for removal of port wine stains, removal of warts, removal of old age spots, fine line wrinkle reduction, mid and deep wrinkle reduction, delivery of cosmaceuticals; associated medical and aesthetic equipment for the laser, energy delivery and energy emitting devices, for removal of port wine stains, removal of warts, removal of old age spots, fine line wrinkle reduction, mid and deep wrinkle reduction, delivery of cosmaceuticals, namely, monitors, display screens sold as a part of medical equipment, hand pieces, namely, pieces that are connected to the table-top units, tips, used as a hygienic interface between the device and the patient, hand piece tips, used as a hygienic interface between the device and the patient, disposable tips, used as a hygienic interface between the device and the patient; special cases for medical instruments | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pantec Biosolutions AG
- Other trademarks owned by Pantec Biosolutions AG
- Other trademarks owned by Pantec Biosolutions AG
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named P.L.E.A.S.E
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 25, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jan 25, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| May 20, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 5, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 5, 2017 | INPC | INVALIDATION PROCESSED | — |
| Jan 27, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 27, 2016 | C71T | CANCELLED SECTION 71 | — |
| Aug 21, 2013 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 21, 2013 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 29, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 22, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 22, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 20, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 20, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 4, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Jul 2, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 1, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 11, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 11, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 3, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 3, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 3, 2009 | ALIE | ASSIGNED TO LIE | — |
| Jun 1, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 3, 2009 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Feb 12, 2009 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 22, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 5, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 5, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 4, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 3, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 2, 2008 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 28, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 28, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Nov 27, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |